???pagination.result.count???
???pagination.result.page???
1
Differential effects of linear and cyclic polyamines on NMDA receptor activities. , Masuko T., Neurochem Int. July 1, 2008; 53 (1-2): 38-44.
Molecular determinants of the anticonvulsant felbamate binding site in the N-methyl-D-aspartate receptor. , Chang HR., J Med Chem. March 27, 2008; 51 (6): 1534-45.
Cleft-type cyclophanes confer neuroprotection against excitatory neurotoxicity in vitro and in vivo through inhibition of NMDA receptors. , Masuko T., Neuropharmacology. September 1, 2007; 53 (4): 515-23.
Cyclophane and acyclic cyclophane: novel channel blockers of N-methyl-D-aspartate receptor. , Masuko T., Neurochem Int. January 1, 2007; 50 (2): 443-9.
NR3A modulates the outer vestibule of the "NMDA" receptor channel. , Wada A., J Neurosci. December 20, 2006; 26 (51): 13156-66.
Pharmacological implications of two distinct mechanisms of interaction of memantine with N-methyl-D-aspartate-gated channels. , Chen HS ., J Pharmacol Exp Ther. September 1, 2005; 314 (3): 961-71.
Anthraquinone polyamines: novel channel blockers to study N-methyl-D-aspartate receptors. , Kashiwagi K ., J Pharmacol Exp Ther. June 1, 2004; 309 (3): 884-93.
Staggering of subunits in NMDAR channels. , Sobolevsky AI., Biophys J. December 1, 2002; 83 (6): 3304-14.
DRPEER: a motif in the extracellular vestibule conferring high Ca2+ flux rates in NMDA receptor channels. , Watanabe J., J Neurosci. December 1, 2002; 22 (23): 10209-16.
Channel blockers acting at N-methyl-D-aspartate receptors: differential effects of mutations in the vestibule and ion channel pore. , Kashiwagi K ., Mol Pharmacol. March 1, 2002; 61 (3): 533-45.
NMDAR channel segments forming the extracellular vestibule inferred from the accessibility of substituted cysteines. , Beck C., Neuron. March 1, 1999; 22 (3): 559-70.
Probing the pore region of recombinant N-methyl-D-aspartate channels using external and internal magnesium block. , Kupper J., Proc Natl Acad Sci U S A. August 6, 1996; 93 (16): 8648-53.